PEOPLE - British In Vitro Diagnostics Association makes appointment:
This article was originally published in Clinica
Colin Andrews has been appointed deputy director of the British In Vitro Diagnostics Association (BIVDA), with effect from April 5. Mr Andrews joins from UK instrumentation, control, automation and laboratory technology industry association GAMBICA, where he was deputy director, focusing on its laboratory technology and international activities, often in close co-operation with BIVDA. During his term at GAMBICA, he left to run the British Laboratory Ware Association (BLWA), but rejoined when GAMBICA's laboratory equipment group amalgamated with the BLWA. His appointment is expected to "hugely increase BIVDA's capacity to manage the variety of functions which the Association has increasingly been involved with".
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.